Article
Alma Lasers has received clearance from the Food and Drug Administration for its new fractionated skin resurfacing module, the company announced.
Test Your Knowledge: Hyperhidrosis and Sweat
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
FDA Sets PFUDA Date, Accepts BLA Submission for Pz-cel in Epidermolysis Bullosa
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Clinical Pearls: PDPA’s 5th Annual Keystone Dermatology Conference
Advancing Representation in Dermatology Research